Ovulation Induction Sample Clauses

Ovulation Induction. I understand that the IVF process involves four phases, only two of which, ovulation induction and egg retrieval, involve my direct participation. I also understand that it cannot be guaranteed that a successful result will be achieved in either of these phases; and that it cannot be guaranteed that the IVF process will result in a pregnancy for the Recipient. I am aware that, if good results are not obtained in either phase, it may be recommended that my participation in the IVF process be terminated and that the IVF cycle be cancelled. It has been explained to me that the ovulation induction phase of the IVF process is intended to control the timing of the release of my eggs and to increase the chance that more than one egg will be produced during the IVF cycle. I have been told that this is accomplished through the use of medications which will first suppress my ovaries and, later, stimulate my ovaries. I have been informed that I will begin taking the medication called Leuprolide Acetate (also called Lupron) starting in the second half of my menstrual cycle to suppress my ovaries. Once Leuprolide Acetate is started, I will be taking this medication as a daily injection for at least two weeks. An ultrasound (a kind of x-ray which uses sound waves instead of radiation) will be taken of my reproductive organs and a blood test will be performed after I have been on Leuprolide Acetate two weeks to make sure that the Leuprolide Acetate has adequately suppressed my ovaries. If the results of the ultrasound and blood test indicate that my ovaries are suppressed, I will be told when to start to take certain active medications which will stimulate the ovaries. These medications include Bravelle, Gonal-F, Follistim, and Repronex. During the stimulation phase, I understand that I will usually be taking one injection each evening of the active medications, along with a single morning injection of Leuprolide Acetate. Occasionally, instead of Leuprolide Acetate, I may be asked to take a medication to help prevent my follicles (the structures which contain my eggs) from releasing an egg before egg retrieval. The medicine, called Antagon or Cetrotide, is started on approximately the fourth to seventh day of my treatment cycle. Additional ultrasound and blood work monitoring will start a few days after the start of the active medications to monitor the development of my follicles, to monitor my hormone levels, and, with this information, to make appropriate adjustments ...
AutoNDA by SimpleDocs

Related to Ovulation Induction

  • Induction The Employer shall provide a copy of this agreement to newly hired employees within the first thirty (30) days of employment and shall introduce newly hired employees to a Union Shop Xxxxxxx in the workplace. The Shop Xxxxxxx will be given an opportunity, not to exceed fifteen (15) minutes, to talk to the new employee. The new employee and the Shop Xxxxxxx will not have wages or benefits deducted during this time.

  • Inductions 57.1 Prior to first attending the site, all Employees shall have successfully completed the Basic Site Induction (Construction Induction Card) course conducted by a RTO. Employees shall provide proof evidencing same if requested.

  • Screening 3.13.1 Refuse containers located outside the building shall be fully screened from adjacent properties and from streets by means of opaque fencing or masonry walls with suitable landscaping.

  • Drug and Alcohol Testing – Safety-Sensitive Functions A. Employees required to have a Commercial Driver’s License (CDL) are subject to pre-employment, post-accident, random and reasonable suspicion testing in accordance with the U.S. Department of Transportation rules, Coast Guard Regulations (46 CFR Part 16) or the Federal Omnibus Transportation Employee Testing Act of 1991. The testing will be conducted in accordance with current Employer policy.

  • Health plan specification The Employer will require health plans participating in the Group Insurance Program to develop and implement health promotion and health education programs for State employees and their dependents.

  • Study Area The study area focused on the Bulk Power System in South-Eastern New York between Albany and New York City, and voltages underlying systems at 115 kV and above in the lower Xxxxxx Valley (Zones G, H & I). In the PSS™E power flow base case provided by NYISO, facilities rated at 115 kV and above in PSS™E designated areas 6 through 11 are monitored in the study. These areas are: • Capital District • Xxxxxx • Millwood • Xxxxxxxxx • Con Ed • Long Island

  • Intake Intake begins when you, or someone on your behalf, contacts the LIFE Provider or the Independent Enrollment Broker expressing interest in services. If it appears from this first conversation that you are potentially eligible, a LIFE Provider and Independent Enrollment Broker representative will contact you to explain the program, obtain further information about you, and to schedule in person or tele-visits. During these visits: • You will learn how the LIFE Program works, the services LIFE offers, and the answers to any questions you may have about LIFE. • The LIFE Provider and/or Independent Enrollment Broker will explain that if you enroll, you must agree that all of your healthcare services will be provided and/or coordinated by LIFE, including primary care and specialist physician services (other than emergency services). • The LIFE Provider will have you sign a release allowing the LIFE Provider to obtain your past medical records so the LIFE health team can fully assess your health conditions. You will be encouraged to visit the LIFE Center to see what it is like. If you are interested in enrolling, a LIFE Provider representative and the Independent Enrollment Broker will assist you with the enrollment process. You should be prepared to participate in phone calls and/or visits with both the LIFE Provider and Independent Enrollment Broker in order to complete your enrollment process.

  • Electrical appliance safety The Hirer shall ensure that any electrical appliances brought by them to the premises and used there shall be safe, in good working order, and used in a safe manner in accordance with the Electricity at Work Regulations 1989. Where a residual circuit breaker is provided the hirer must make use of it in the interests of public safety.

  • Study Population ‌ Infants who underwent creation of an enterostomy receiving postoperative care and awaiting enterostomy closure: to be assessed for eligibility: n = 201 to be assigned to the study: n = 106 to be analysed: n = 106 Duration of intervention per patient of the intervention group: 6 weeks between enterostomy creation and enterostomy closure Follow-up per patient: 3 months, 6 months and 12 months post enterostomy closure, following enterostomy closure (12-month follow-up only applicable for patients that are recruited early enough to complete this follow-up within the 48 month of overall study duration).

  • Vaccination and Inoculation (a) The Employer agrees to take all reasonable precautions, including in-service seminars, to limit the spread of infectious diseases among employees.

Time is Money Join Law Insider Premium to draft better contracts faster.